Other Non-current Assets - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) royalty_payment payment	Mar. 31, 2023 USD ($)	Jun. 30, 2020 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues	$ 12,053	$ 11,134
Number of guaranteed royalty payments | royalty_payment	8
License agreement with Sunovion Pharmaceuticals, Inc.
Acquired Finite-Lived Intangible Assets [Line Items]
Minimum annual royalty receivable	$ 1,000		$ 1,000
Number of annual royalty payments receivable | payment	4
Royalty
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues	$ (12)	$ (989)
Royalty | License agreement with Sunovion Pharmaceuticals, Inc.
Acquired Finite-Lived Intangible Assets [Line Items]
Revenues			$ 8,000